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The efficacy of quantitative fluorescent-polymerase
chain reaction (QF-PCR) in the diagnosis of prenatal
aneuploidy
Aim: To investigate the efficacy of quantitative fluorescent-polymerase chain reaction (QF-PCR) in
the diagnosis of aneuploidy.
Materials and methods: The study included 40 pregnant women considered to be at high risk, based
on positive trisomy 21 screening results, that underwent amniocentesis for karyotyping to detect
chromosomal anomalies. In amniotic fluid aneuploidy detection was carried out by both standard
karyotyping and the QF-PCR method, and the results obtained with both methods were compared.
In order to determine the efficacy of QF-PCR, its sensitivity, specificity, positive predictive value
(PPV), and negative predictive value (NPV) were calculated.
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Results: Of the 40 patients’ results obtained with the 2 methods, 32 were similar. In 31 of these 32
cases, chromosome analysis interpreted as normal by QF-PCR was also established to be normal by
standard karyotype analysis and 1 case evaluated as trisomy by QF-PCR was also determined to be
trisomy 21 by standard karyotype analysis. In 6 cases, however, results were evaluated as
chromosomal abnormality by QF-PCR, whereas standard analysis found them to be normal. The
efficacy indices of QF-PCR were as follows: sensitivity 50%, specificity 83.7%, PPV 14.3%, and NPV
96.9%.
Conclusion: Until the efficacy of QF-PCR increases, along with the sophistication of the technique,
conventional karyotype analysis will remain the gold standard.
Key words: Aneuploidy, QF-PCR conventional karyotype analysis

Prenatal anöploidi saptanmasında kantitatif floresan-polimeraz zincir
reaksiyonu (QF-PCR) yönteminin etkinliği
Amaç: Bu çalışmanın amacı, uygun prenatal dönemde anöploidi tanısında kullanılan Kantitatif
Floresan-Polimeraz Zincir Reaksiyonu (QF-PCR) yönteminin etkinliğinin araştırılmasıdır.
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Yöntem ve gereçler: Trizomi 21 taraması sonucu pozitif olan ve bu nedenle yüksek riskli grup olarak
kabul edildikten sonra kromozomal anomali araştırılması amacıyla amniosentez yapılan 40 gebe
çalışmaya alındı. Amnion sıvısında hem standart karyotipleme ile kromozom analizi yapıldı, hem de
QF-PCR metodu ile anöploidi incelemesi yapıldı. Her iki metod ile elde edilen sonuçlar karşılaştırıldı
ve QF-PCR yönteminin etkinliğinin ortaya konması için sensitivite, spesifisite, pozitif ve negatif
prediktif değerler (PPV, NPV) hesaplandı.
Bulgular: Her iki yöntemin sonuçları 40 olgudan 32’sinde benzerdi. Bu 32 olgudan 31’inde, QF-PCR
yönteminde normal olarak değerlendirilen olguların standart karyotip analizinde normal karyotipe
sahip olduğu kesinleştirildi ve QF-PCR yöntemi sonucu Trizomi 21 olarak değerlendirilen 1 olguda
da standart karyotipleme sonucu Trizomi 21 olarak rapor edildi. 6 olguda ise QF-PCR sonuçları
anormal olarak değerlendirilirken standart analizde bu olguların normal oldukları görüldü. QFPCR’ın etkinlik göstergeleri, sensitivite % 50, spesifisite % 83,7, PPV % 14,3 ve NPV % 96,9 idi.
Sonuç: Teknikteki gelişme ile birlikte QF-PCR metodunun etkinliği artana kadar konvansiyonel
karyotip analizi altın standart olarak kalmaya devam etmektedir.
Anahtar sözcükler: Anöploidi, QF-PCR, konvansiyonel karyotip analizi
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Introduction
Pregnant women with a high risk of carrying
fetuses with chromosomal anomalies due to maternal
age, abnormal serum biochemical markers, or
abnormal ultrasonography findings, are evaluated by
standard fetal karyotyping of fetal cells obtained from
amniotic fluid or fetal blood via amniocentesis,
chorionic villus sampling (CVS), or cordocentesis,
which are all invasive methods. These conventional
cytogenetic analyses remain the gold standard in the
prenatal diagnosis of chromosomal anomalies (1).
Of these methods, the most frequently used for
more than 25 years is the karyotyping of cells obtained
from amniotic fluid; however, as the growth of cell
cultures takes at least 10 days (optimum: 21 days),
waiting for the results creates anxiety, for both the
families and physicians.
Recently, various diagnostic methods that yield
results in 24-48 h have been developed so that families
and physicians are not subjected to an anxious waiting
process. FISH (fluorescence in situ hybridization),
QF-PCR (quantitative fluorescent-polymerase chain
reaction), CGH (comparative genomic hybridization),
and MLPA (multiplex ligation-dependent probe
amplification) are the most frequently used of these
methods (1-5). The aim of the present study was to
compare the efficacy of QF-PCR, which yields results
in 24-48 h, and standard karyotyping in the detection
of chromosomal anomalies.
Materials and methods
Of the pregnant women that presented to Atatürk
Education and Research Hospital, Obstetrics and
Gynecology Department Antenatal Unit between June
2006 and April 2007, 40 pregnant women that
th
th
underwent amniocentesis between the 16 and 20
gestational week (after consent for invasive
intervention was obtained from the women and their
spouses) due to positive screening results for trisomy
21 (those with a combined risk over 1/250) on one of
the double or triple screening tests were included in the
study. Amniotic fluid samples (20 mL) were obtained
via amniocentesis guided by ultrasonography; 5 mL
was used for QF-PCR and 15 mL was used for
conventional cytogenetic analysis. Conventional
cytogenetic analysis was performed by a private genetic
laboratory. QF-PCR analysis was carried out in our
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laboratory with an ABI PRISM 310 device, using a
multiplex QF-PCR rapid diagnosis kit for trisomy 21,
18, and 13, and sex chromosome aneuploidies
(AneufastTM QF-PCR). The Aneufast™ QF-PCR kit
contains 6 multiplex markers (2 of them [S1, S2] for
performing initial aneuploidy screening in a single
electrophoresis, and 4 of them [M21, M13, M18, and
MXY] chromosome-specific markers) and sets of short
tandem repeats (STRs) that can be used for
amplification of selected microsatellites and the
amelogenin-SRY (sex determining region) (genes on
the Y chromosome). This combination of markers
allows the detection of aneuploidies involving
chromosomes X, Y, 21, 18, and 13 for non-mosaic
trisomies. This method is intended to be used to
amplify DNA extracted from fresh prenatal samples,
such as amniotic fluid, chorionic villus samples, or fetal
blood. The Aneufast™ QF-PCR Kit uses a 5-dye
fluorescent system for automated DNA fragment
analysis. This allows multiplex amplification and
electrophoresis of loci. In normal individuals
heterozygous for the STRs, the same amount of
fluorescence is generated for both alleles; therefore, the
ratio between the area (and height) of the fluorescent
peaks is 1:1. In homozygous individuals STR alleles
have the same repeat number and size; therefore,
quantification is not possible and the marker is
uninformative. In a trisomic sample the 3 copies of a
chromosome can be detected, as the corresponding
chromosome-specific STRs show 3 peaks with the
same fluorescent intensity and a ratio between the areas
of 1:1:1 (trisomic triallelic). If 2 chromosomes have the
same repeat number, quantitative PCR will produce 2
unbalanced fluorescent peaks with an area ratio of 2:1
(trisomic diallelic). Triploid samples will produce
trisomic diallelic and triallelic patterns for informative
STRs on all chromosomes. Due to the occasional
preferential amplification of the smaller allele, the
ratios between fluorescent peaks may vary within
limits; ≤ 0.6-≥ 1.8:1 are assessed as trisomy.
The results of the QF-PCR rapid detection test
were analyzed and interpreted by the author (S.B.G.),
with the help of the geneticist of the private laboratory.
In each case, standard karyotype and QF-PCR
results were compared in order to determine the
efficacy of QF-PCR; its sensitivity, specificity, and
positive and negative predictive values (PPV, NPV)
were calculated.

Vol: 39

No: 5

The efficacy of QF-PCR in prenatal aneuploidy detection

Results
Mean age of the patients was 30.9 ± 7.1 years,
mean number of gravidity was 2.9 ± 1.5, mean
number of parity was 1.2 ± 0.7, and mean gestational
age was 16 weeks + 6 days ± 1 week + 1 day. Of the 40
patients included in the study, the results of the 2
methods were similar in 32 (Table). In 31 of these
cases chromosome analysis that was evaluated as
normal by QF-PCR was also found to be normal by
conventional karyotype analysis, and 1 case evaluated
as aneuploidy (trisomy 21) by QF-PCR was
interpreted in the same way by karyotype analysis. In
6 cases, although results were interpreted as
aneuploidic anomaly in 13, 18, 21, and sex
chromosomes by QF-PCR, they were found to be
normal by karyotype analysis (false positive).
Conversely, in 1 case QF-PCR interpreted the results
as normal and conventional karyotype analysis
determined the presence of 47, XYY chromosome
(false negative). In 34 cases the results were obtained
24 h after the samples arrived at the laboratory. In 4
cases QF-PCR results were obtained in 48 h and in 1
case in 72 h because the analysis had to be repeated. In
1 patient interpretation could not be made because
the amniotic fluid was hemorrhagic. The efficacy
indexes of QF-PCR were as follows: sensitivity 50%,
specificity 83.7%, PPV 14.3%, and NPV 96.9%.
Discussion
Trisomy in 13, 18, 21, and sex chromosomes
constitute 60%-80% of abnormalities detected in
amniotic fluid cultures (2). The stage of the cell
culture, which lasts for 10-21 days before karyotype
analysis, delays the process. Yet, with this method, the
failure rate or the rate of negative cultures is lower
than 0.5% (3).
The examination of amniotic fluid or CVS samples
that are not cultured by molecular methods yields
results much more rapidly, i.e. in 24-48 h. It is possible
to detect aneuploidies of chromosomes 13, 18, and 21,
and sex chromosomes by these methods.
QF-PCR, a rapid method for the detection of
chromosomal aneuploidies in uncultured amniocytes,
is a molecular screening method in which certain
short tandem repeats on known chromosome loci are
amplified by polymerase chain reaction. The test,
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thus, does not analyze chromosomes; only some
markers are amplified to evaluate the number of
copies of certain chromosomes, such as 13, 18, 21, X,
and Y. A conventional karyotype analysis reveals the
structure and number of all chromosomes, and
detection sensitivity depends on the number of bands
on the chromosomes. Nevertheless, these methods
miss 15%-30% of anomalies detected by conventional
karyotyping (4-9).
The FISH technique was approved by the FDA in
1997. It has been reported that the success rate of
FISH and QF-PCR techniques in detecting trisomies
of chromosome 13, 18, and 21 in those without
mosaicism is around 70%-80% (2,4). Yılmaz et al.
reported that the results of conventional cytogenetic
and FISH methods were compatible in 48 out of 51
patients (5). In a comprehensive study carried out by
Caine et al. in 2005, samples from 119,528 patients
that underwent amniocentesis were examined and
abnormal karyotypes were detected in 3081, and
among those 2075 were examined using rapid
aneuploid diagnosis methods (PCR and FISH);
however, these methods were not successful in 1006
patients. Their sensitivity was hence reported to be
67% and the authors concluded that none of the 3
technologies—full karyotyping, PCR, and FISH—was
completely reliable for detecting an abnormal
karyotype, but that the best protocol for an
interpretable result was to use PCR and karyotyping,
or FISH and karyotyping, and that replacement of full
karyotyping with rapid testing for trisomies 13, 18,
and 21 after a positive screening for Down’s syndrome
will result in a substantial number of live born
children with hitherto preventable mental or physical
handicaps, and represents a substantial change in the
outcome quality of prenatal testing offered to couples
(4). In a study conducted by Mann et al. in 2001, QFPCR yielded no false positive or false negative results
in 1148 amniotic fluid samples and 188 CVS samples.
Its sensitivity was reported to be 96.8%, its specificity
99.8%, and its PPV 96.7% (10). These tests have low
success rates in the detection of other structural
chromosomes and sex chromosome anomalies. Their
most marked drawback is that they are unable to
define small segment imbalances. Additionally, they
cannot establish ring chromosomes or unbalanced
translocations (3).
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Table. Indications and results in the patients.
Case
no.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40

Age

G

P

Indication
results

Pregnancy
week

Cytogenetic
results

QF-PCR

31
27
36
35
40
38
31
32
23
26
27
26
20
26
33
28
40
32
26
18
22
31
27
25
28
43
26
27
32
27
20
44
43
29
38
41
38
26
43
25

2
3
2
3
6
3
4
2
1
4
1
2
1
1
5
2
2
3
4
2
1
3
1
3
3
6
3
3
2
2
1
4
3
2
4
2
3
3
6
1

1
2
1
2
2
2
1
1
0
1
0
1
0
0
2
1
1
2
2
1
0
1
0
2
1
2
2
1
1
0
0
1
1
1
3
1
2
2
2
0

TST/ DS
TST/ DS
DST/ DS
TST/ DS
TST/ DS
TST/ DS
TST/ DS
DST/ DS
TST/ DS
TST/ DS
TST/ DS
TST/ DS
TST/ DS
TST/ DS
TST/ DS
TST/ DS
AMA
TST/ DS
DST/ DS
TST/ DS
TST/ DS
TST/ DS
TST/ DS
TST/ DS
DST/ DS
AMA
TST/ DS
TST/ DS
TST/ DS
TST/ DS
TST/ DS
AMA
TST/ DS
TST/ DS
TST/ DS
TST/ DS
TST/ DS
DS history of prior child
DST/ DS+AMA
TST/ DS

17 +3/7
16 +3/7
16
18 +1/7
17
20
18 +2/7
16 +1/7
17 +2/7
16 +5/7
16 +5/7
19 +3/7
19
18 +5/7
17 +3/7
16 +6/7
18 +6/7
18 +2/7
16
18
18 +4/7
17 +1/7
17
18 +3/7
17 +2/7
19 +5/7
19
17 +4/7
17
17
16 +5/7
18 +2/7
17 +3/7
16 +5/7
17 +2/7
18 +5/7
18 +3/7
18
16 +4/7
16 +2/7

46, XX
46, XY
46, XX
46, XX
46, XX
46, XY
46, XY
46, XX
46, XY
46, XY
46, XX
46, XY
46, XY
46, XY
46, XX
46, XY
46, XX
46, XX
46, XY
46, XY
46, XX
46, XY
46, XX
46, XY
46, XY
46, XY
46, XX
46, XX
46, XY
46, XY
46, XX
46, XX
46, XY
46, XY
46, XX
46, XY
46, XX
47, XY, +Y
47, XY, +21
46, XY

N, XX
N, XY
N, XX
N, XX
N, XX
N, XY
N, XY
N, XX
N, XY
N, XY
N, XX
N, XY
N, XY
N, XY
N, XX
N, XY
N, XX
N, XX
N, XY
N, XY
N, XX
N, XY
N, XX
N, XY
N, XY
N, XY
N, XX
N, XX
N, XY
N, XY
N, XX
Trisomy 21, XX
Trisomy 21, XY
Trisomy 21, XY
Trisomy 21, XX
Trisomy 21, XY
Trisomy 21, XX
N, XY
Trisomy 21, XY
Hemorrhagic
AF, No comment

N: Two signals each for chromosome 13, 18, 21, X, and Y; DS: Down’s syndrome; AMA: advanced maternal age; TST: Triple Screening
Test; DST: Dual Screening Test; AF: amnion fluid.
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Although FISH and QF-PCR can be applied to all
chromosomes, they are routinely used merely for 13,
18, 21, and sex chromosomes. Their rate of detection
for all chromosome anomalies may be as low as 65%
(3,11). The advantage of QF-PCR over FISH is that it
can be used with less amniotic fluid and it is easier to
perform. In addition, it can also detect maternal cell
contamination. The FISH method is more effective
than QF-PCR in mosaic subjects. When using the
FISH method with non-hemorrhagic amniotic fluid,
maternal contamination is not a serious problem
because the geneticist can distinguish maternal
contamination by investigating at least 100 cells.
The most important drawback of rapid tests is the
problem of establishing mosaic cases and sex
chromosome anomalies. In the present study a case
identified as karyotype 47, XYY by conventional
analysis was missed by QF-PCR.
QF-PCR and MLPA are more cost effective than
FISH and can be used in larger series of patients.
MLPA relies on the dose measurement of genomic
sequences. Another advantage is that it can detect the
40 different genomic loci and mosaicism better than
other tests (2).
As the sensitivity of rapid screening tests is as low
as 70%-80% in mosaic cases and sex chromosomes,
conventional cytogenetic analysis remains the method
of choice for many patients. In the present study the
sensitivity and specificity of QF-PCR was 83.7% and
50%, respectively. In addition, conventional
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karyotyping may detect numerical and structural
anomalies other than trisomies (4).
In conclusion, given that a diagnostic test should be
inexpensive, easily applicable, highly sensitive and
specific, and reproducible when used in clinical
practice, it can be stated that it is premature to use rapid
tests in daily practice, because they can be used only for
selected chromosomes (13, 18, 21 and sex
chromosomes), have a high rate of failure, and maternal
DNA contamination can influence the results.
For all rapid screening methods used during
genetic counseling, it is important to inform patients
that undergo aneuploidy screening by rapid screening
methods about the advantages and disadvantages of
the method in order to help them acknowledge the
results in the event that an abnormality is identified in
the karyotype. Rapid screening tests are never
regarded as definitive.
Although the specificity and sensitivity values were
not very high in the present study, in the future,
following technological development of these tests,
their efficacy may be expected to increase, shortening
the waiting time before results are obtained and
decreasing the anxiety experienced by waiting
families. Nonetheless, until these advances are made,
as these rapid techniques can detect only the
numerical abnormalities of chromosomes 13, 18, 21,
X, and Y, conventional karyotyping, which has a
failure rate lower than 0.5% at present, will remain the
gold standard for chromosome analysis.
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